These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11863357)

  • 1. Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.
    Barber TD; Barber MC; Tomescu O; Barr FG; Ruben S; Friedman TB
    Genomics; 2002 Mar; 79(3):278-84. PubMed ID: 11863357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG
    Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
    Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
    Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K;
    Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ
    Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.
    Keller C; Arenkiel BR; Coffin CM; El-Bardeesy N; DePinho RA; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2614-26. PubMed ID: 15489287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
    Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ
    Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
    Barr FG; Qualman SJ; Macris MH; Melnyk N; Lawlor ER; Strzelecki DM; Triche TJ; Bridge JA; Sorensen PH
    Cancer Res; 2002 Aug; 62(16):4704-10. PubMed ID: 12183429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
    Keller C; Hansen MS; Coffin CM; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3.
    Anderson MJ; Shelton GD; Cavenee WK; Arden KC
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1589-94. PubMed ID: 11171995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
    Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ
    Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma.
    Barr FG; Nauta LE; Davis RJ; Schäfer BW; Nycum LM; Biegel JA
    Hum Mol Genet; 1996 Jan; 5(1):15-21. PubMed ID: 8789435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
    Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
    Kempf BE; Vogt PK
    Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.
    Davis RJ; Barr FG
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
    Bennicelli JL; Edwards RH; Barr FG
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
    Frascella E; Toffolatti L; Rosolen A
    Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
    Collins MH; Zhao H; Womer RB; Barr FG
    Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.